Suven Pharmaceuticals informs about disclosure

06 Dec 2023 Evaluate

Suven Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

Suven Pharma Share Price

1186.45 2.15 (0.18%)
16-Apr-2025 12:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.25
Dr. Reddys Lab 1150.50
Cipla 1495.60
Lupin 1985.90
Zydus Lifesciences 872.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...